Market Overview:
The United States intravenous solution market is currently witnessing moderate growth. Intravenous (IV) solutions are a complete mix of essential nutrients that help to replenish fluid loss, treat electrolyte imbalance and maintain fluid balance in IV therapy. These solutions provide nutrients to patients who have diabetes, cancer, and other such diseases. IV solutions contain water with electrolytes, sugar, or medications added in concentrations according to the patient’s medical condition, age and body size. Furthermore, the manufacturers are coming up with new and innovative products, such as premixed solutions that provide better convenience and reduce packaging wastage.
The United States IV solution market is primarily driven by the growing prevalence of lifestyle diseases and the increasing geriatric population. Besides this, a well-developed healthcare industry, coupled with high per capita healthcare expenditure and the ready availability of IV solutions are also propelling the growth of the market across the country. The rising prevalence of gastrointestinal and neurological diseases is also acting as another major growth-inducing factor. Moreover, IV solutions are available in portable packages, thus making it easy for the patients to use drips from within the comfort of their homes. This, in turn, is creating a positive outlook for the market in the United States. As a result of these factors, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the United States intravenous solution market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.
Breakup by Type:
- Partial Parenteral Nutrition
- Total Parenteral Nutrition
Breakup by Nutrients:
- Carbohydrates
- Salts and Electrolytes
- Minerals
- Vitamins
- Amino Acids
Breakup by Region:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the United States intravenous solutions market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the United States intravenous solutions market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the nutrients?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the United States intravenous solutions market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 United States Intravenous Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Partial Parenteral Nutrition
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Total Parenteral Nutrition
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Nutrients
7.1 Carbohydrates
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Salts and Electrolytes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Minerals
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Vitamins
7.4.1 Market Trends
7.4.2市场ecast
7.5 Amino Acids
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1 Northeast
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Midwest
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 South
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 West
8.4.1 Market Trends
8.4.2 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Policy and Regulatory Landscape
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
List of Figures
Figure 1: United States: Intravenous Solutions Market: Major Drivers and Challenges
Figure 2: United States: Intravenous Solutions Market: Sales Value (in Million US$), 2015-2020
Figure 3: United States: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: United States: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 5: United States: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 6: United States: Intravenous Solutions Market: Breakup by Region (in %), 2020
Figure 7: United States: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: United States: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: United States: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: United States: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: United States: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: United States: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: United States: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: United States: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: United States: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: United States: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2021-2026
图17:美国:静脉注射解决方案(Vitamins) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: United States: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: United States: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: United States: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Northeast: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Northeast: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Midwest: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Midwest: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: South: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: South: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: West: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: West: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: United States: Intravenous Solutions Industry: SWOT Analysis
Figure 30: United States: Intravenous Solutions Industry: Value Chain Analysis
Figure 31: United States: Intravenous Solutions Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: United States: Intravenous Solutions Market: Key Industry Highlights, 2020 and 2026
Table 2: United States: Intravenous Solutions Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: United States: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million US$), 2021-2026
Table 4: United States: Intravenous Solutions Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: United States: Intravenous Solutions Market: Competitive Structure
Table 6: United States: Intravenous Solutions Market: Key Players